|
04 May 2007 |
Indevus Announces FDA Approval of SUPPRELIN(R)-LA
|
|
03 May 2007 |
RegeneRx Receives IND to Begin Cardiovascular Clinical Program
|
|
02 May 2007 |
Phosphagenics to commence insulin clinical trial in May
|
|
02 May 2007 |
Spectrum Announces Completion Of Target Enrollment In Ozarelix Phase 2b Trial In Benign Prostate Hypertrophy
|
|
01 May 2007 |
Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
|
|
01 May 2007 |
Sangamo BioSciences Announces Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
|
|
01 May 2007 |
RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery
|
|
01 May 2007 |
FDA Approves SoloSTAR(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes
|
|
01 May 2007 |
Cardiome Announces In-Licensing Agreement with Eli Lilly and Company
|
|
01 May 2007 |
Humate-P(R) Approved to Prevent Excessive Bleeding in Patients with von Willebrand Disease Undergoing Surgery
|
|
25 Apr 2007 |
Beyond biogenerics: the real threats for therapeutic proteins
|
|
25 Apr 2007 |
Allon Therapeutics confirms oral bioavailability of AL-309
|
|
25 Apr 2007 |
Study Shows Ambrilia's Therapeutic Peptide PCK3145 Has Clinical Activity In Metastatic Prostate Cancer Patients
|
|
25 Apr 2007 |
Protox Doses First Patient In Benign Prostatic Hyperplasia Trial Using PRX302
|
|
24 Apr 2007 |
Hemispherx and Armada Health Care enter Agreement to Launch Alferon N Injection(R) via Specialty Pharmacy Network
|
|
21 Apr 2007 |
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
|
|
21 Apr 2007 |
Cleveland BioLabs Protectan CBLB612 Demonstrates Efficacy in Stimulating Proliferation and Mobilization of Bone Marrow Stem Cells in Primate Model
|
|
20 Apr 2007 |
Aranesp(R) ''145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
|
|
19 Apr 2007 |
Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD. Phase III clinical trial may commence shortly
|
|
19 Apr 2007 |
Viragen Announces European Multiferon(R) Licensing Agreement
|
|
18 Apr 2007 |
Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
|
|
18 Apr 2007 |
DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
|
|
18 Apr 2007 |
Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322
|
|
18 Apr 2007 |
Prevascar Phase II Results
|
|
18 Apr 2007 |
OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic
|
